Together with partners, the Malaghan Institute is building New Zealand’s capability for vaccine development, including against COVID-19.
We're exploring the therapeutic potential of human hookworms to ultimately find better treatment options for a range of inflammatory and autoimmune diseases, including coeliac, asthma, allergy, MS and IBD.
Malaghan visiting researcher: Dr Michelle Linterman
27 January 2023
In Focus: How gene-editing technology is pushing the boundaries of exploration into the immune system
16 January 2023
Clinical study shows booster needed to protect against Omicron
22 December 2022
In Focus: Uncovering the mysteries of asthma and allergy development
12 December 2022
RNZ Saturday Morning: Prof Mike Berridge – recognising vital work in cellular science
5 December 2022
Professor Mike Berridge: A journey through the frontiers of the biological sciences
28 November 2022